| __timestamp | CRISPR Therapeutics AG | Ultragenyx Pharmaceutical Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 1513000 | 45967000 |
| Thursday, January 1, 2015 | 12573000 | 114737000 |
| Friday, January 1, 2016 | 42238000 | 183204000 |
| Sunday, January 1, 2017 | 69800000 | 231644000 |
| Monday, January 1, 2018 | 113773000 | 293998000 |
| Tuesday, January 1, 2019 | 179362000 | 357355000 |
| Wednesday, January 1, 2020 | 266946000 | 412084000 |
| Friday, January 1, 2021 | 438633000 | 497153000 |
| Saturday, January 1, 2022 | 461645000 | 705789000 |
| Sunday, January 1, 2023 | 387332000 | 648449000 |
| Monday, January 1, 2024 | 320653000 |
Unveiling the hidden dimensions of data
In the rapidly evolving world of biotechnology, research and development (R&D) investments are crucial for driving innovation and breakthroughs. Over the past decade, Ultragenyx Pharmaceutical Inc. and CRISPR Therapeutics AG have been at the forefront of this endeavor. Since 2014, Ultragenyx has consistently outpaced CRISPR in R&D spending, with a peak investment in 2022 that was approximately 53% higher than CRISPR's. This trend underscores Ultragenyx's commitment to pioneering treatments and therapies.
CRISPR Therapeutics, known for its groundbreaking gene-editing technology, has also shown a robust increase in R&D expenditure, growing by over 250% from 2014 to 2023. This surge highlights the company's dedication to advancing genetic research. As we look to the future, these investments are expected to yield significant advancements in medical science, potentially transforming patient care and treatment outcomes.
Research and Development: Comparing Key Metrics for argenx SE and Ultragenyx Pharmaceutical Inc.
Analyzing R&D Budgets: Insmed Incorporated vs CRISPR Therapeutics AG
R&D Spending Showdown: BioMarin Pharmaceutical Inc. vs CRISPR Therapeutics AG
R&D Insights: How Jazz Pharmaceuticals plc and Ultragenyx Pharmaceutical Inc. Allocate Funds
R&D Spending Showdown: Blueprint Medicines Corporation vs Ultragenyx Pharmaceutical Inc.
Amneal Pharmaceuticals, Inc. or Ultragenyx Pharmaceutical Inc.: Who Invests More in Innovation?
R&D Spending Showdown: Ultragenyx Pharmaceutical Inc. vs Xencor, Inc.
Comparing Innovation Spending: CRISPR Therapeutics AG and Protagonist Therapeutics, Inc.
Who Prioritizes Innovation? R&D Spending Compared for CRISPR Therapeutics AG and Amphastar Pharmaceuticals, Inc.
Research and Development Expenses Breakdown: CRISPR Therapeutics AG vs Mesoblast Limited
CRISPR Therapeutics AG vs Galapagos NV: Strategic Focus on R&D Spending
Research and Development Expenses Breakdown: CRISPR Therapeutics AG vs BioCryst Pharmaceuticals, Inc.